Generation Historical Financial Ratios
| GBIO Stock | USD 1.16 0.03 2.52% |
Generation Bio is recently reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.55 or Days Sales Outstanding of 280 will help investors to properly organize and evaluate Generation Bio financial condition quickly.
Generation |
About Generation Financial Ratios Analysis
Generation BioFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Generation Bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Generation financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Generation Bio history.
Generation Bio Financial Ratios Chart
Add Fundamental
Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Roic
Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Generation Bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Generation Bio current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Generation Bio's Graham Net Net is very stable compared to the past year. As of the 16th of December 2024, Price Book Value Ratio is likely to grow to 0.55, while Book Value Per Share is likely to drop 2.72.
| 2023 | 2024 (projected) | Graham Number | 11.8 | 11.64 | Receivables Turnover | 1.28 | 1.35 |
Generation Bio fundamentals Correlations
Click cells to compare fundamentals
Generation Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Generation Bio fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | (11.57) | 2.88 | 1.04 | 0.81 | 0.52 | 0.55 | |
| Book Value Per Share | (2.13) | 9.83 | 6.78 | 4.86 | 3.15 | 2.72 | |
| Free Cash Flow Yield | (0.0529) | (0.0979) | (0.25) | (0.49) | (0.57) | (0.54) | |
| Operating Cash Flow Per Share | (0.87) | (2.57) | (1.63) | (1.76) | (0.82) | (0.86) | |
| Capex To Depreciation | 10.72 | 1.61 | 1.31 | 1.72 | 1.41 | 1.34 | |
| Pb Ratio | (11.57) | 2.88 | 1.04 | 0.81 | 0.52 | 0.55 | |
| Free Cash Flow Per Share | (1.31) | (2.78) | (1.74) | (1.91) | (0.93) | (0.98) | |
| Roic | 0.62 | (0.29) | (0.3) | (0.47) | (0.65) | (0.62) | |
| Net Income Per Share | (1.31) | (2.81) | (2.04) | (2.27) | (1.96) | (2.06) | |
| Cash Per Share | 0.33 | 9.62 | 6.66 | 4.8 | 4.1 | 3.91 | |
| Pocfratio | (28.28) | (11.02) | (4.34) | (2.23) | (2.02) | (2.12) | |
| Capex To Operating Cash Flow | (0.5) | (0.0787) | (0.0649) | (0.0859) | (0.14) | (0.15) | |
| Pfcf Ratio | (18.91) | (10.21) | (4.08) | (2.05) | (1.77) | (1.86) | |
| Income Quality | 0.66 | 0.87 | 0.77 | 0.75 | 0.42 | 0.78 | |
| Roe | 0.61 | (0.29) | (0.3) | (0.47) | (0.62) | (0.59) | |
| Ev To Operating Cash Flow | (27.91) | (10.12) | (1.14) | (2.12) | (2.61) | (2.74) | |
| Pe Ratio | (18.91) | (10.1) | (3.48) | (1.73) | (0.84) | (0.88) | |
| Ev To Free Cash Flow | (18.66) | (9.38) | (1.07) | (1.95) | (2.29) | (2.41) | |
| Earnings Yield | (0.0529) | (0.099) | (0.29) | (0.58) | (1.19) | (1.13) | |
| Net Debt To E B I T D A | 0.25 | 0.81 | 2.57 | 0.0843 | (0.24) | (0.22) | |
| Current Ratio | 1.98 | 23.86 | 20.16 | 14.99 | 6.83 | 10.61 | |
| Tangible Book Value Per Share | (2.13) | 9.83 | 6.78 | 4.86 | 3.15 | 2.72 | |
| Graham Number | 7.92 | 24.92 | 17.63 | 15.77 | 11.8 | 11.64 | |
| Shareholders Equity Per Share | (2.13) | 9.83 | 6.78 | 4.86 | 3.15 | 2.72 | |
| Graham Net Net | (2.71) | 8.67 | 4.98 | 3.19 | 1.48 | 1.74 | |
| Enterprise Value Over E B I T D A | (18.63) | (9.14) | (0.91) | (1.59) | (1.03) | (1.09) | |
| Price Earnings Ratio | (18.91) | (10.1) | (3.48) | (1.73) | (0.84) | (0.88) | |
| Price Book Value Ratio | (11.57) | 2.88 | 1.04 | 0.81 | 0.52 | 0.55 | |
| Price To Operating Cash Flows Ratio | (28.28) | (11.02) | (4.34) | (2.23) | (2.02) | (2.12) | |
| Price To Free Cash Flows Ratio | (18.91) | (10.21) | (4.08) | (2.05) | (1.77) | (1.86) | |
| Ebt Per Ebit | 0.98 | 0.99 | 1.0 | 0.97 | 0.91 | 1.07 | |
| Effective Tax Rate | 0.0161 | 0.05 | 0.0376 | 0.0332 | 0.0299 | 0.0152 |
Pair Trading with Generation Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Generation Stock
Moving against Generation Stock
| 0.85 | BMY | Bristol Myers Squibb | PairCorr |
| 0.79 | ESPR | Esperion Therapeutics | PairCorr |
| 0.78 | DYAI | Dyadic International | PairCorr |
| 0.65 | GILD | Gilead Sciences | PairCorr |
| 0.4 | DNA | Ginkgo Bioworks Holdings Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.
The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 0.28 | Quarterly Revenue Growth 2.52 | Return On Assets (0.19) | Return On Equity (0.86) |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.